Payer decision-making with limited comparative and cost effectiveness data: the case of new pharmacological treatments for gout
Michele Meltzer, Laura T Pizzi, Eric Jutkowitz
BMJ Evidence-Based Medicine Aug 2012, 17 (4) 105-108; DOI: 10.1136/ebmed-2011-100065